← FDA DRUG APPROVALS

FDA ANDA · ANDA062946

AMOXICILLIN

Sponsor: TEVA

APPLICATION
ANDA062946
TYPE
ANDA
ORIGINAL APPROVAL
1988-11-01
LATEST ACTION
2000-02-01
ROUTE
ORAL
DOSAGE FORM
FOR SUSPENSION
MARKETING STATUS
Discontinued

Products

AMOXICILLINDiscontinued
AMOXICILLIN 125MG/5ML · FOR SUSPENSION · ORAL

Approval history

2000-02-01Labeling · Supplement 9AP
1999-07-07Labeling · Supplement 7AP
1996-09-13Manufacturing (CMC) · Supplement 6AP
1995-02-24Manufacturing (CMC) · Supplement 4AP
1994-02-23Manufacturing (CMC) · Supplement 5AP
1993-05-27Manufacturing (CMC) · Supplement 3AP
1993-05-27Manufacturing (CMC) · Supplement 2AP
1992-03-24Manufacturing (CMC) · Supplement 1AP
1988-11-01OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →